Epidemiological characteristics of patients with idiopathic normal pressure hydrocephalus in Japan: analysis of the treatment by unknown
ORAL PRESENTATION Open Access
Epidemiological characteristics of patients with
idiopathic normal pressure hydrocephalus in
Japan: analysis of the treatment
Madoka Nakajima*, Masakazu Miyajima, Chihiro Akiba, Ikuko Ogino, Hajime Arai
From Hydrocephalus 2015
Banff, Canada. 18-21 September 2015
Introduction
To clarify the epidemiological and clinical characteristics
of idiopathic normal pressure hydrocephalus (iNPH) in
Japan, a nationwide epidemiological survey was con-
ducted, focusing on treatment analysis.
Methods
Study participants were selected according to hospital bed
capacity, using a random sampling method. In a primary
survey, the number of iNPH patients in each hospital
department during the year 2012 was estimated for strati-
fication of institutions and next, in a secondary survey,
selected patients provided detailed information, determin-
ing the clinical and epidemiological features of interest.
Results
In the primary survey 1804 clinical departments
responded (recovery rate: 42.7% ) for 3079 individuals,
including 1815 individuals who underwent shunt surgery.
The estimated annual number of patients receiving treat-
ment was 13,000 (95% CI: 10000 to 16000). The esti-
mated prevalence rate for hospital-based patients in 2012
was 10.2 individuals per 100,000.
Analyses were conducted on 1495 respondents (885
males (59.2%): age 77.9±6.30(SD) years; and 610 females
(40.8%): age 78.0±6.41 years. Results showed 992 iNPH
patients (66.1%) treated with shunt surgery, 547 patients
(77.6±6.12yo) with lumboperitoneal (LPS), 428 patients
(76.51±6.19yo) with ventriculoperitoneal (VPS) and 17
with vetriculoatrial (VAS) shunting. Four patients having
both LPS and VPS.
In 120 out of 992 shunted patients were recorded
complications (12.1%), including 77 out of 547 patients
with LPS and 43 out 428 patients with VPS, without sta-
tistically significant difference between the two sub-
groups (p=0.092).
Therapeutic efficacy exceeded 90% with improvement of
1 point or higher on the modified Rankin Scale (mRS) in
56%. Age and Alzheimer’s Disease were factors with a nega-
tive impact on the therapeutic prognosis, with odds ratio of
1.029 95%CI (1.013-1.047) p=0.001, and 1.365 95% CI
(1.008-1.849) p=0.044, respectively. They had significant
impact on the prognosis of improvement according to mRS.
Conclusions
We reported hospital based survey study in Japan, pro-
viding the main characteristics of iNPH epidemiology
and management for 2012.
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